UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cancer cell, ISSN 1535-6108, 04/2007, Volume 11, Issue 4, pp. 321 - 333
CELLCYCLE | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Adenomatous Polyposis Coli Protein - physiology | Wnt1 Protein - genetics | Oligonucleotide Array Sequence Analysis | Adenocarcinoma, Mucinous - pathology | Humans | PTEN Phosphohydrolase - physiology | Cystadenocarcinoma, Serous - metabolism | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Gene Expression Profiling | Phosphatidylinositol 3-Kinases - metabolism | Wnt1 Protein - metabolism | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | Tumor Suppressor Protein p53 - genetics | Carcinoma, Endometrioid - metabolism | Ovarian Neoplasms - genetics | Female | Ovarian Neoplasms - metabolism | Disease Models, Animal | Ovary - metabolism | Adenomatous Polyposis Coli Protein - genetics | PTEN Phosphohydrolase - genetics | Carcinoma, Endometrioid - genetics | Epithelium - pathology | Ovary - pathology | Epithelium - metabolism | Signal Transduction | Adenocarcinoma, Clear Cell - metabolism | Tumor Suppressor Protein p53 - metabolism | Survival Rate | beta Catenin - metabolism | beta Catenin - genetics | Phosphatidylinositol 3-Kinases - genetics | Animals | Adenocarcinoma, Mucinous - metabolism | Adenocarcinoma, Clear Cell - pathology | Mice | Adenocarcinoma, Mucinous - genetics | Mutation | Neoplasm Staging | Adenocarcinoma, Clear Cell - genetics | Carcinoma, Endometrioid - pathology | Index Medicus
Journal Article
Gynecologic oncology, ISSN 0090-8258, 2011, Volume 124, Issue 1, pp. 15 - 20
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Immunohistochemistry | Endometrial cancer | Uterine papillary serous and clear cell carcinoma | Type I and II | Grade 3 endometrioid | Survival | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Receptors, Estrogen - metabolism | Carcinoma, Endometrioid - classification | Endometrial Neoplasms - classification | Humans | Middle Aged | Endometrial Neoplasms - metabolism | Receptor, ErbB-2 - metabolism | Tumor Suppressor Protein p53 - metabolism | Survival Rate | Carcinoma, Endometrioid - metabolism | Receptors, Progesterone - metabolism | Neoplasm Grading | Aged, 80 and over | Adult | Endometrial Neoplasms - pathology | Female | Aged | Neoplasm Staging | Carcinoma, Endometrioid - pathology | Carcinoma | Research | Oncology, Experimental | Cancer | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 08/2014, Volume 74, Issue 18, pp. 5103 - 5117
Life Sciences & Biomedicine | Oncology | Science & Technology | Cell Proliferation | Cadherins - metabolism | Humans | Endometrial Neoplasms - metabolism | Gene Expression Profiling | Carcinoma, Endometrioid - metabolism | DNA Methylation | Heterografts | Endometrial Neoplasms - genetics | Female | Cadherins - genetics | Promoter Regions, Genetic | Carcinoma, Endometrioid - genetics | Down-Regulation | Gene Silencing | RNA, Long Noncoding - genetics | beta Catenin - metabolism | beta Catenin - genetics | Animals | Wnt Signaling Pathway - genetics | Mice, Nude | Cell Line, Tumor | Endometrial Neoplasms - pathology | Apoptosis - physiology | RNA, Long Noncoding - metabolism | Carcinoma, Endometrioid - pathology | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 02/2019, Volume 125, Issue 3, pp. 398 - 405
recurrence | endometrial cancer | adjuvant treatment | mismatch repair (MMR) deficiency | high‐intermediate–risk | high-intermediate–risk | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunohistochemistry | Prognosis | Endometrial Neoplasms - mortality | Humans | Endometrial Neoplasms - metabolism | Neoplastic Syndromes, Hereditary - metabolism | Carcinoma, Endometrioid - diagnosis | Brain Neoplasms - metabolism | Colorectal Neoplasms - diagnosis | Carcinoma, Endometrioid - metabolism | Neoplastic Syndromes, Hereditary - mortality | DNA Repair Enzymes - metabolism | Biomarkers, Tumor - metabolism | Female | Retrospective Studies | Brain Neoplasms - mortality | Colorectal Neoplasms - metabolism | Colorectal Neoplasms - mortality | Neoplasm Recurrence, Local - metabolism | Biomarkers, Tumor - analysis | Brain Neoplasms - diagnosis | Risk Factors | Neoplastic Syndromes, Hereditary - diagnosis | Neoplasm Recurrence, Local - diagnosis | Endometrial Neoplasms - diagnosis | DNA Repair Enzymes - analysis | Carcinoma, Endometrioid - mortality | Survival Analysis | Endometrial Neoplasms - pathology | Aged | Carcinoma, Endometrioid - pathology | Endometrial cancer | MLH1 protein | MSH2 protein | Health risks | Vagina | Homology | Regression analysis | Patients | Survival | Proteins | MSH6 protein | Survival analysis | Correlation analysis | Mismatch repair | Risk assessment | Biomarkers | Hazard assessment | Repair | Endometrium | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 10/2009, Volume 33, Issue 10, pp. 1504 - 1514
Adenocarcinoma | Immunohistochemistry | P16 | Uterus | Endometrioid carcinoma | Serous carcinoma | Endocervical adenocarcinoma | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Gynecology. Andrology. Obstetrics | Investigative techniques, diagnostic techniques (general aspects) | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Biological and medical sciences | Medical sciences | Female genital diseases | Tumors | Humans | Cystadenocarcinoma, Serous - metabolism | Endometrial Neoplasms - metabolism | Cystadenocarcinoma, Serous - genetics | Carcinoma, Endometrioid - diagnosis | Papillomavirus Infections - diagnosis | Tumor Suppressor Protein p53 - genetics | Carcinoma, Endometrioid - metabolism | Endometrial Neoplasms - genetics | Uterine Cervical Neoplasms - metabolism | DNA Mutational Analysis | Polymerase Chain Reaction | Cyclin-Dependent Kinase Inhibitor p16 - biosynthesis | Female | Uterine Neoplasms - diagnosis | Uterine Neoplasms - genetics | Carcinoma, Endometrioid - genetics | Diagnosis, Differential | Papillomavirus Infections - complications | Uterine Neoplasms - metabolism | Uterine Cervical Neoplasms - diagnosis | Biomarkers, Tumor - analysis | In Situ Hybridization, Fluorescence | Endometrial Neoplasms - diagnosis | Papillomavirus Infections - metabolism | Uterine Cervical Neoplasms - virology | Cystadenocarcinoma, Serous - diagnosis | Index Medicus
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 07/2020, Volume 44, Issue 7, pp. 982 - 990
Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Immunohistochemistry | Carcinoma, Endometrioid - genetics | Prognosis | Follow-Up Studies | Ovarian Neoplasms - diagnosis | Tissue Array Analysis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Carcinoma, Endometrioid - diagnosis | Carcinoma, Endometrioid - metabolism | Ovarian Neoplasms - genetics | Biomarkers, Tumor - metabolism | Adult | Female | Aged | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Ovarian Neoplasms - metabolism | Retrospective Studies | Mutation | Neoplasm Staging | Carcinoma, Endometrioid - pathology | Index Medicus
Journal Article
The FEBS journal, ISSN 1742-464X, 08/2013, Volume 280, Issue 16, pp. 3768 - 3779
microRNA | endometrioid endometrial cancer | cyclin D1 | miR‐503 | target gene | miR-503 | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Cyclin D1 - metabolism | Cell Proliferation | Humans | Middle Aged | Endometrial Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | MicroRNAs - metabolism | Endometrial Hyperplasia - pathology | Endometrial Neoplasms - prevention & control | Carcinoma, Endometrioid - metabolism | Cyclin D1 - antagonists & inhibitors | Endometrial Hyperplasia - metabolism | Female | 3' Untranslated Regions | Genes, Reporter | Endometrial Hyperplasia - prevention & control | Endometrium - metabolism | Recombinant Proteins - metabolism | Gene Transfer Techniques | Recombinant Proteins - antagonists & inhibitors | Xenograft Model Antitumor Assays | Carcinoma, Endometrioid - prevention & control | Animals | Cell Cycle | Cyclin D1 - genetics | Mice, Nude | Cell Line, Tumor | Endometrial Neoplasms - pathology | Aged | Mice | MicroRNAs - genetics | Endometrium - pathology | Carcinoma, Endometrioid - pathology | Development and progression | MicroRNA | Genetic transcription | Endometrial cancer | Cancer | Cell growth | Gene expression | MicroRNAs | Cell cycle | Index Medicus
Journal Article
Cancer letters, ISSN 0304-3835, 2016, Volume 383, Issue 1, pp. 28 - 40
Hematology, Oncology and Palliative Medicine | MALAT1 | Endometrioid endometrial carcinoma | miR-200c | Invasion | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Endometrial Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | MicroRNAs - metabolism | Carcinoma, Endometrioid - metabolism | Transfection | Endometrial Neoplasms - genetics | RNA Interference | Time Factors | Epithelial-Mesenchymal Transition | Biomarkers, Tumor - metabolism | Female | 3' Untranslated Regions | Binding Sites | Carcinoma, Endometrioid - genetics | Signal Transduction | Neoplasm Invasiveness | RNA, Long Noncoding - genetics | Tumor Burden | Cell Movement - drug effects | Transforming Growth Factor beta - pharmacology | Animals | Mice, Nude | Cell Line, Tumor | Endometrial Neoplasms - pathology | Biomarkers, Tumor - genetics | Mice, Inbred BALB C | MicroRNAs - genetics | RNA, Long Noncoding - metabolism | Carcinoma, Endometrioid - pathology | Medical colleges | Carcinoma | Melanoma | Antisense RNA | Metastasis | Transforming growth factors | Ovarian cancer | Prevention | Analysis | Stem cells | Bone morphogenetic proteins | Health aspects | Cancer | Index Medicus
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 01/2021, Volume 45, Issue 1, pp. 68 - 76
Carcinoma, Endometrioid - genetics | Prognosis | Biomarkers, Tumor - analysis | beta Catenin - analysis | Humans | Middle Aged | Treatment Outcome | Ovarian Neoplasms - mortality | beta Catenin - metabolism | beta Catenin - genetics | Carcinoma, Endometrioid - metabolism | Ovarian Neoplasms - genetics | Disease-Free Survival | Carcinoma, Endometrioid - mortality | Aged, 80 and over | Adult | Female | Aged | Ovarian Neoplasms - metabolism | Mutation | Index Medicus
Journal Article
Pathology oncology research, ISSN 1219-4956, 2016, Volume 22, Issue 4, pp. 863 - 868
Immunohistochemistry | Prognostic value | Pathology | Biomedicine | Immunology | Cancer Research | Oncology | Non-endometrioid | L1CAM | Endometrial carcinoma | Biomedicine general | Histopathological diagnosis | Life Sciences & Biomedicine | Science & Technology | Prognosis | Endometrial Neoplasms - mortality | Humans | Middle Aged | Endometrial Neoplasms - metabolism | Survival Rate | Disease Progression | Carcinoma, Endometrioid - metabolism | Young Adult | Disease-Free Survival | Carcinoma, Endometrioid - mortality | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Endometrial Neoplasms - pathology | Female | Aged | Neural Cell Adhesion Molecule L1 - metabolism | Carcinoma, Endometrioid - pathology | Carcinoma | Cancer | Index Medicus | Short Communication
Journal Article
International journal of gynecological pathology, ISSN 0277-1691, 01/2019, Volume 38, Issue 1, pp. 44 - 51
NF-κB | Androgen receptor | Endometrial endometrioid carcinoma | Mismatch repair genes | Pathology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Immunohistochemistry | Neoplastic Syndromes, Hereditary - pathology | Receptors, Estrogen - metabolism | Humans | Receptors, Androgen - metabolism | Brain Neoplasms - pathology | Endometrial Neoplasms - metabolism | NF-kappa B - metabolism | Neoplastic Syndromes, Hereditary - metabolism | DNA Mismatch Repair - genetics | Brain Neoplasms - metabolism | Case-Control Studies | Carcinoma, Endometrioid - metabolism | Receptors, Progesterone - metabolism | DNA Methylation | Endometrial Neoplasms - pathology | Female | Aged | MutL Protein Homolog 1 - metabolism | Androgens - metabolism | Colorectal Neoplasms - pathology | Carcinoma, Endometrioid - pathology | Colorectal Neoplasms - metabolism | Cohort Studies | Development and progression | Genetic aspects | Endometrial cancer | Health aspects | DNA mismatch repair | Index Medicus
Journal Article